These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18521513)

  • 1. Simultaneous detection and epitope mapping of anti-factor VIII antibodies.
    Lavigne-Lissalde G; Tarrade C; Lapalud P; Chtourou S; Schved JF; Granier C; Villard-Saussine S
    Thromb Haemost; 2008 Jun; 99(6):1090-6. PubMed ID: 18521513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
    Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
    Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human hybridoma clones isolated from hemophilia patients with specificity for different domains of coagulating factor VIII.
    Gharagozlou S; Ghods R; Bahrami ZS; Roohi A; Jeddi-Tehrani M; Conti-Fine BM; Sharifian RA; Rabbani H; Shokri F
    Hum Antibodies; 2003; 12(3):67-76. PubMed ID: 14646035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
    Scandella D; Reyes H; Felch M; Sakurai Y
    Haematologica; 2000 Oct; 85(10 Suppl):86-8. PubMed ID: 11187882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.
    Lavigne-Lissalde G; Rothschild C; Pouplard C; Lapalud P; Gruel Y; Schved JF; Granier C
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):67-79. PubMed ID: 19172415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
    Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
    Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
    Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restricted epitope specificity of anti-FVIII antibodies that appeared during a recent outbreak of inhibitors.
    Gilles JG; Peerlinck K; Arnout J; Vermylen J; Saint-Remy JM
    Thromb Haemost; 1997 May; 77(5):938-43. PubMed ID: 9184406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantibodies to factor VIII in haemophilia.
    Zakarija A; Harris S; Rademaker AW; Brewer J; Krudysz-Amblo J; Butenas S; Mann KG; Green D
    Haemophilia; 2011 Jul; 17(4):636-40. PubMed ID: 21299745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC; Lasne D; Rothschild C; Siali R; Jozefonvicz J
    Thromb Haemost; 2004 Feb; 91(2):259-66. PubMed ID: 14961152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors.
    Lebreton A; Lapalud P; Chambost H; Biron-Andréani C; Morange PE; Combescure C; Marquès-Verdier A; Berger C; Schved JF; Granier C; Lavigne-Lissalde G
    Thromb Haemost; 2011 Jun; 105(6):954-61. PubMed ID: 21475776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV; Dasgupta S; Andre S; Navarrete AM; Repessé Y; Wootla B; Lacroix-Desmazes S
    Haemophilia; 2007 Dec; 13 Suppl 5():61-4. PubMed ID: 18078399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobiology of inhibitor development in hemophilia A.
    Fijnvandraat K; Bril WS; Voorberg J
    Semin Thromb Hemost; 2003 Feb; 29(1):61-8. PubMed ID: 12640567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin.
    Huang CC; Shen MC; Chen JY; Hung MH; Hsu TC; Lin SW
    Br J Haematol; 2001 Jun; 113(4):915-24. PubMed ID: 11442484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.